Indicators

Markets:

News

Latest News about TAK

Recent news which mentions TAK

< Previous 1 2 3 4 5 6 7 8 Next >

Seagen's Adcetris/Immunotherapy Combo Achieves 98% Overall Response Rate in Early-Stage Lymphoma Setting

June 13, 2023

3 Stocks That Could Skyrocket by This Time Next Summer

June 08, 2023

Why Shares of Innate Pharma Jumped Thursday

June 08, 2023

FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq

May 19, 2023

Takeda Moves Out From Licensing Agreement With Theravance Biopharma

May 11, 2023

Earnings Scheduled For May 11, 2023

May 11, 2023

Takeda's FY22 Net Profit Jumps 38%, But Expects Lower FY23 Revenues

May 11, 2023

Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More

April 25, 2023

Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday

April 25, 2023

This Supercharged Dividend King Stock Might Soon Run Out of Steam

April 25, 2023

United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review

April 21, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

April 11, 2023

Etsy To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday

April 04, 2023

Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says

March 20, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023

March 16, 2023

Johnson & Johnson's Experimental Dengue Pill Shows Efficacy In Animal Studies

March 15, 2023

Should You Give Up on Novavax?

March 03, 2023

2 Incredibly Cheap High-Yield Dividend Stocks to Buy Now

February 28, 2023

Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients

February 21, 2023

Is This the Telltale Sign to Sell Novavax Stock?

February 14, 2023

Takeda Reports 13% Fall In Nine Month Operating Profit, Keeps Annual Guidance Unchanged

February 02, 2023

7 Sorry Dividend Stocks to Sell in February Before It’s Too Late

January 30, 2023

Finch Therapeutics Halts Work On Its Only Clinical Stage Asset, Cuts 95% Of Workforce

January 24, 2023

HUTCHMED Out Licenses Fruquintinib To Takeda Outside China

January 23, 2023

Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study

January 09, 2023

A Bullish Sign Appears On Takeda Pharmaceutical's Chart

December 28, 2022

Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies

December 14, 2022

Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B

December 13, 2022

Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting

December 09, 2022

Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?

November 30, 2022

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.